Generic placeholder image

Current Diabetes Reviews


ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

The Role of Adipocytokines and Neurohormonal Dysregulation in Metabolic Syndrome


Volume 2 , Issue 4 , 2006

Page: [397 - 407] Pages: 11

DOI: 10.2174/1573399810602040397

Price: $58


Metabolic syndrome, also known as the insulin resistance syndrome (IRS), dysmetabolic syndrome or syndrome X, is a burgeoning global epidemic. This constellation of risk factors, namely glucose intolerance, hypertension, dyslipidemia (high triglyceride and low HDL cholesterol), central obesity, pro-inflammatory and prothrombotic state, culminating to the development of premature cardiovascular and renal disease, has significant impact on life expectancy, societal productivity and quality of life. The underlying mechanism of this complex syndrome remains to be elucidated. In recent years, light has been shed on the roles of neuroendocrine system and adipocytokines on the pathogenesis of IRS. In this review, we summarize the possible links between insulin and various hormones (growth hormones (GH), catecholamines, glucocorticoids and sex hormones), partly mediated through visceral adiposity and adipocytokines (notably adiponectin, leptin, resistin, visfatin, tumor necrosis factor α (TNF-α), interleukin-6 (IL-6)) in the pathogenesis of this syndrome.

Keywords: Adipocytokines, Neurohormonal Dysregulation, Insulin Resistance Syndrome, Metabolic Syndrome

Rights & Permissions Print Export Cite as
Related Journals
Related eBooks
Article Metrics
Related Articles
© 2020 Bentham Science Publishers